Craig Bennison

593 total citations · 1 hit paper
22 papers, 393 citations indexed

About

Craig Bennison is a scholar working on Pathology and Forensic Medicine, Ophthalmology and Oncology. According to data from OpenAlex, Craig Bennison has authored 22 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 4 papers in Ophthalmology and 4 papers in Oncology. Recurrent topics in Craig Bennison's work include Bladder and Urothelial Cancer Treatments (3 papers), Metabolism and Genetic Disorders (3 papers) and Retinal and Macular Surgery (3 papers). Craig Bennison is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Metabolism and Genetic Disorders (3 papers) and Retinal and Macular Surgery (3 papers). Craig Bennison collaborates with scholars based in United States, Netherlands and Switzerland. Craig Bennison's co-authors include Gian Luca Di Tanna, Michael Urbich, Gary Globe, Heidi S. Wirtz, Marieke Heisen, Krystallia Pantiri, Barbara Potrata, John Brazier, Michael Wang and Sally W. Wade and has published in prestigious journals such as SHILAP Revista de lepidopterología, Value in Health and PharmacoEconomics.

In The Last Decade

Craig Bennison

21 papers receiving 380 citations

Hit Papers

A Systematic Review of Medical Costs Associated with Hear... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)
    2020 246 citations Michael Urbich, Gary Globe et al. PharmacoEconomics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig Bennison United States 7 212 47 45 43 41 22 393
Nitish Naik India 14 297 1.4× 44 0.9× 15 0.3× 27 0.6× 16 0.4× 67 512
Jun Hwan Cho South Korea 9 185 0.9× 25 0.5× 14 0.3× 45 1.0× 7 0.2× 25 329
Özcan Özdemır Türkiye 13 351 1.7× 33 0.7× 11 0.2× 108 2.5× 16 0.4× 45 562
Stefania Lopatriello Italy 10 39 0.2× 52 1.1× 68 1.5× 53 1.2× 44 1.1× 35 340
Purva Jain United States 11 214 1.0× 21 0.4× 10 0.2× 34 0.8× 48 1.2× 27 501
Jo Jo Hai Hong Kong 17 598 2.8× 65 1.4× 25 0.6× 84 2.0× 8 0.2× 53 750
Yuen‐Kwun Wong Hong Kong 11 137 0.6× 30 0.6× 11 0.2× 141 3.3× 13 0.3× 22 499
Frédéric Balusson France 14 73 0.3× 35 0.7× 56 1.2× 36 0.8× 5 0.1× 38 469
Remigijus Žaliūnas Lithuania 15 471 2.2× 129 2.7× 11 0.2× 56 1.3× 16 0.4× 76 690
Jessica Chow United States 8 88 0.4× 28 0.6× 34 0.8× 58 1.3× 17 0.4× 14 386

Countries citing papers authored by Craig Bennison

Since Specialization
Citations

This map shows the geographic impact of Craig Bennison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Bennison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Bennison more than expected).

Fields of papers citing papers by Craig Bennison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Bennison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Bennison. The network helps show where Craig Bennison may publish in the future.

Co-authorship network of co-authors of Craig Bennison

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Bennison. A scholar is included among the top collaborators of Craig Bennison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Bennison. Craig Bennison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeshima, Takao, et al.. (2024). Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective. PharmacoEconomics. 42(7). 811–822. 2 indexed citations
2.
3.
4.
Bennison, Craig, et al.. (2022). POSB96 Economic Model for a Gene Therapy in an Ultra-Rare Disease: Expert Validation of Approach and Assumptions. Value in Health. 25(1). S79–S79. 1 indexed citations
5.
6.
Salles, Gilles, Michael Wang, James J. Wu, et al.. (2022). Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England. Journal of Medical Economics. 25(1). 730–740. 6 indexed citations
7.
Barbier, Michaela, et al.. (2021). Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland. The European Journal of Health Economics. 23(5). 837–846. 13 indexed citations
8.
Houwing, Natalie, Xiaofeng Wang, Heidi C. Waters, et al.. (2021). An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia. PharmacoEconomics. 40(1). 121–131. 3 indexed citations
9.
Malone, Daniel C., Michael Wang, Gregory A. Maglinte, et al.. (2021). Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States. Journal of Medical Economics. 24(1). 421–431. 18 indexed citations
10.
Tanna, Gian Luca Di, Michael Urbich, Heidi S. Wirtz, et al.. (2020). Health State Utilities of Patients with Heart Failure: A Systematic Literature Review. PharmacoEconomics. 39(2). 211–229. 29 indexed citations
11.
12.
Urbich, Michael, Gary Globe, Krystallia Pantiri, et al.. (2020). A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020). PharmacoEconomics. 38(11). 1219–1236. 246 indexed citations breakdown →
13.
Khanani, Arshad M., Pravin U. Dugel, Julia A. Haller, et al.. (2020). Cost–effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US. Journal of Comparative Effectiveness Research. 9(4). 287–305.
14.
15.
Gonzalez‐McQuire, Sebastian, Meletios Α. Dimopoulos, Katja Weisel, et al.. (2019). Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making. MDM Policy & Practice. 4(1). 3442462765–3442462765. 12 indexed citations
16.
Gonzalez‐McQuire, Sebastian, Craig Bennison, Krystallia Pantiri, et al.. (2015). Development of A Conceptual Model of Multiple Myeloma for Use In Economic Modelling: A Systematic Literature Review to Identify The Evidence Base. Value in Health. 18(7). A701–A701. 1 indexed citations
17.
Gonzalez‐McQuire, Sebastian, Craig Bennison, Wei Xu, et al.. (2015). Development and Validation of A Conceptual Model of Multiple Myeloma. Value in Health. 18(7). A698–A698. 1 indexed citations
18.
19.
Marteau, Florence, et al.. (2013). Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer. Value in Health. 16(7). A408–A409. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nitish Naik Breakdown of academic impact, for papers by Jun Hwan Cho Breakdown of academic impact, for papers by Özcan Özdemır Breakdown of academic impact, for papers by Stefania Lopatriello Breakdown of academic impact, for papers by Purva Jain Breakdown of academic impact, for papers by Jo Jo Hai Breakdown of academic impact, for papers by Yuen‐Kwun Wong Breakdown of academic impact, for papers by Frédéric Balusson Breakdown of academic impact, for papers by Remigijus Žaliūnas Breakdown of academic impact, for papers by Jessica Chow
Rankless by CCL
2026